BI 1569912
id:
bi-1569912-194-14820726
title:
BI 1569912
text:
BI 1569912 is a selective modulator of the NMDA receptor. It is being developed by Boehringer Ingelheim to treat major depressive disorder. As of 2023, it is in a Phase I trial.
brand slug:
wiki
category slug:
encyclopedia
description:
original url:
https://en.wikipedia.org/wiki/BI_1569912
date created:
date modified:
2023-11-05T10:23:25Z
main entity:
{"identifier":"Q123481262","url":"https://www.wikidata.org/entity/Q123481262"}
image:
fields total:
13
integrity:
13